Anterogen.Co.Ltd (065660) - Total Liabilities

Latest as of September 2025: ₩1.40 Billion KRW ≈ $951.49K USD

Based on the latest financial reports, Anterogen.Co.Ltd (065660) has total liabilities worth ₩1.40 Billion KRW (≈ $951.49K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Anterogen.Co.Ltd operating cash flow efficiency to assess how effectively this company generates cash.

Anterogen.Co.Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Anterogen.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 065660 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Anterogen.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Anterogen.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Windlas Biotech Limited NSE:WINDLAS	India	Rs2.80 Billion
Hong Leong Capital Bhd KLSE:5274	Malaysia	RM3.85 Billion
AgriFORCE Growing Systems Ltd NASDAQ:AGRI	USA	$4.36 Million
Dynamic Cables Limited NSE:DYCL	India	Rs1.97 Billion
Polaris Infrastructure Inc TO:PIF	Canada	CA$309.19 Million
Solara Active Pharma Sciences Limited NSE:SOLARA	India	Rs10.36 Billion
Michlol Finance Ltd TA:MCLL	Israel	ILA1.79 Billion
Greenx Metals Ltd AU:GRX	Australia	AU$3.96 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Anterogen.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Anterogen.Co.Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	41.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anterogen.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual total liabilities of Anterogen.Co.Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.87 Billion ≈ $3.98 Million	-70.65%
2023-12-31	₩19.99 Billion ≈ $13.54 Million	+15.25%
2022-12-31	₩17.34 Billion ≈ $11.75 Million	-12.57%
2021-12-31	₩19.83 Billion ≈ $13.44 Million	+50.98%
2020-12-31	₩13.14 Billion ≈ $8.90 Million	-18.91%
2019-12-31	₩16.20 Billion ≈ $10.98 Million	-64.29%
2018-12-31	₩45.37 Billion ≈ $30.75 Million	+293.48%
2017-12-31	₩11.53 Billion ≈ $7.81 Million	+721.17%
2016-12-31	₩1.40 Billion ≈ $951.53K	-24.04%
2015-12-31	₩1.85 Billion ≈ $1.25 Million	+22.79%
2014-12-31	₩1.51 Billion ≈ $1.02 Million	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$194.04 Million

₩286.33 Billion KRW

Market Cap Rank

#16652 Global

#717 in Korea

Share Price

₩36000.00

Change (1 day)

-4.26%

52-Week Range

₩19850.00 - ₩58000.00

All Time High

₩197700.00